Jovana Rajković is SeniorResearch Associate, employed at the Institute for Pharmacology, Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Belgrade. She finished her PhD thesis in 2020. The title of her PhD thesis was “The effects of potassium channel opener on isolated bypass graft patients with type 2 diabetes mellitus”. Between 2013 and 2020 she participated in the national project: “Development of technological process for manufacturing a red wine and dietary supplements from the red wine with a high concentration of bioactive polyphenols with cardioprotective effects” (TR 31020) funded by the Ministry of Education, Science and Technological Development of Republic of Serbia. During her PhD studies in Medical Pharmacology, she was staying at the Institute of Physiology, University of Tübingen, Germany. Also, she was participant of the summer school “COME” Systemic medicine in cardiovascular diseases, held in September 2017 in Hamburg, Germany. As a member of the Humboldt bilateral project: "The effects of the polyphenol resveratrol and synthetic SIRT-1 modulators on the function of voltage–sensitive potassium channels expressed in the membrane of different tumor cells" during the 2017-2019 cycles, she attended two professional training sessions at the Max Planck Institute for Experimental Medicine in Göttingen, Germany. She is listed among top 10% of Research Associates based on excellence in science in Serbia.
Jovana Rajković is SeniorResearch Associate, employed at the Institute for Pharmacology, Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Belgrade. She finished her PhD thesis in 2020. The title of her PhD thesis was “The effects of potassium channel opener on isolated bypass graft patients with type 2 diabetes mellitus”. Between 2013 and 2020 she participated in the national project: “Development of technological process for manufacturing a red wine and dietary supplements from the red wine with a high concentration of bioactive polyphenols with cardioprotective effects” (TR 31020) funded by the Ministry of Education, Science and Technological Development of Republic of Serbia. During her PhD studies in Medical Pharmacology, she was staying at the Institute of Physiology, University of Tübingen, Germany. Also, she was participant of the summer school “COME” Systemic medicine in cardiovascular diseases, held in September 2017 in Hamburg, Germany. As a member of the Humboldt bilateral project: "The effects of the polyphenol resveratrol and synthetic SIRT-1 modulators on the function of voltage–sensitive potassium channels expressed in the membrane of different tumor cells" during the 2017-2019 cycles, she attended two professional training sessions at the Max Planck Institute for Experimental Medicine in Göttingen, Germany. She is listed among top 10% of Research Associates based on excellence in science in Serbia.